urea has been researched along with quinoxalines in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (16.67) | 18.7374 |
1990's | 2 (16.67) | 18.2507 |
2000's | 4 (33.33) | 29.6817 |
2010's | 2 (16.67) | 24.3611 |
2020's | 2 (16.67) | 2.80 |
Authors | Studies |
---|---|
Ryley, JF; Wilson, RG | 1 |
Harkness, DR; Stadtman, ER | 1 |
Bauer, PM; Buga, GM; Fukuto, JM; Ignarro, LJ; Wei, LH | 1 |
Belonga, KL; Carter, DB; Im, HK; Im, WB; Jacobsen, EJ; Mickelson, JW; Petke, JD; Sethy, VH; Stelzer, LS; Tang, AH; TenBrink, RE; VonVoigtlander, PF; Zhong, WZ | 1 |
Brown, T; Bunton, D; MacDonald, A; McGrath, JC; Shaw, AM; Tracey, A | 1 |
Bohme, GA; Boireau, A; Damour, D; Debono, MW; Genevois-Borella, A; Imperato, A; Jimonet, P; Mignani, S; Pratt, J; Randle, JC; Ribeill, Y; Stutzmann, JM; Vuilhorgne, M | 1 |
Bonci, A; Borgland, SL; Fields, HL; Sarti, F; Taha, SA | 1 |
Li, J; Li, X; Qiu, B; Shen, J; Wang, X; Xiong, B; Zhang, L | 1 |
Bickle, QD; Cowan, N; Ingram-Sieber, K; Keiser, J; Mansour, NR; Panic, G; Spangenberg, T; Vargas, M; Wells, TN | 1 |
Anderson, MO; Cil, O; Diez-Cecilia, E; Lee, S; Verkman, AS | 1 |
Chen, MW; Li, X; Zhao, ZB; Zhao, ZK; Zhou, YG | 1 |
Contreras, JI; Ezell, EL; Garrison, JC; Kizhake, S; Mallareddy, JR; Napoleon, JV; Natarajan, A; Radhakrishnan, P; Rajesh, C; Rana, S; Sagar, S; Singh, S; Sonawane, YA | 1 |
12 other study(ies) available for urea and quinoxalines
Article | Year |
---|---|
Comparative studies with anticoccidials and three species of chicken coccidia in vivo and in vitro.
Topics: Amprolium; Animals; Antiprotozoal Agents; Benzoates; Chickens; Coccidiosis; Culture Techniques; Eimeria; Kidney; Niacinamide; Poultry Diseases; Quinolines; Quinoxalines; Urea | 1972 |
Bacterial degradation of riboflavin. VI. Enzymatic conversion of riboflavin to 1-ribityl-2,3-diketo-1,2,3,4-tetrahydro-6, 7-dimethylquinoxaline, urea, and carbon dioxide.
Topics: Ammonia; Biphenyl Compounds; Borates; Carbon Dioxide; Copper; Flavin Mononucleotide; Flavins; In Vitro Techniques; Kinetics; Mercury; Phenanthrolines; Pseudomonas; Quinoxalines; Riboflavin; Sulfites; Urea | 1965 |
NG-hydroxy-L-arginine and nitric oxide inhibit Caco-2 tumor cell proliferation by distinct mechanisms.
Topics: Animals; Aorta; Arginase; Arginine; Caco-2 Cells; Cell Division; Coculture Techniques; DNA; Endothelium, Vascular; Humans; Nitric Oxide; Nitric Oxide Donors; Ornithine; Ornithine Decarboxylase; Oxadiazoles; Polyamines; Putrescine; Quinoxalines; Rats; Spermidine; Spermine; Thymidine; Triazenes; Urea | 1998 |
Piperazine imidazo[1,5-a]quinoxaline ureas as high-affinity GABAA ligands of dual functionality.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Anxiety; Biological Availability; Cell Line; Cerebellum; Convulsants; Cyclic GMP; Drug Evaluation, Preclinical; GABA Agonists; Imidazoles; In Vitro Techniques; Ligands; Male; Mice; Models, Molecular; Molecular Conformation; Pentylenetetrazole; Piperazines; Quinoxalines; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Receptors, GABA-A; Seizures; Structure-Activity Relationship; Urea | 1999 |
5-hydroxytryptamine- and U46619-mediated vasoconstriction in bovine pulmonary conventional and supernumerary arteries: effect of endogenous nitric oxide.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arteries; Cattle; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanylate Cyclase; Indoles; Lung; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Quinoxalines; Serotonin; Serotonin Antagonists; Urea; Vasoconstrictor Agents | 2000 |
4,10-Dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid derivatives: highly potent and selective AMPA receptors antagonists with in vivo activity.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anticonvulsants; Drug Evaluation, Preclinical; Inhibitory Concentration 50; Isoquinolines; Mice; Mice, Inbred DBA; Pyrazines; Quinoxalines; Rats; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship; Tetrazoles; Urea | 2000 |
Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine.
Topics: Analysis of Variance; Anesthetics, Local; Animals; Animals, Newborn; Behavior, Animal; Benzoxazoles; Calcium Channel Blockers; Cocaine; Cyclic AMP; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Immunohistochemistry; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Lysine; Male; Motor Activity; N-Methylaspartate; Naphthyridines; Neuronal Plasticity; Neurons; Neuropeptides; Orexins; Patch-Clamp Techniques; Protein Kinase C; Quinoxalines; Rats; Rats, Sprague-Dawley; Synapses; Thionucleotides; Time Factors; Tyrosine 3-Monooxygenase; Urea; Ventral Tegmental Area | 2006 |
Quinoxalinylurea derivatives as a novel class of JSP-1 inhibitors.
Topics: Allosteric Site; Dual-Specificity Phosphatases; Enzyme Inhibitors; Inhibitory Concentration 50; Mitogen-Activated Protein Kinase Phosphatases; Phosphoprotein Phosphatases; Protein Phosphatase 1; Protein Tyrosine Phosphatases; Quinoxalines; Structure-Activity Relationship; Urea | 2007 |
Orally active antischistosomal early leads identified from the open access malaria box.
Topics: Administration, Oral; Animals; Anthelmintics; Disease Models, Animal; Female; Inhibitory Concentration 50; Mice; Parasite Load; Parasitic Sensitivity Tests; Quinoxalines; Schistosoma mansoni; Schistosomiasis mansoni; Urea | 2014 |
Nanomolar-Potency 1,2,4-Triazoloquinoxaline Inhibitors of the Kidney Urea Transporter UT-A1.
Topics: Animals; Diuresis; Diuretics; Dogs; Humans; Kidney; Madin Darby Canine Kidney Cells; Male; Membrane Transport Proteins; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Osmolar Concentration; Quinoxalines; Rats; Rats, Wistar; Structure-Activity Relationship; Urea; Urea Transporters | 2018 |
Biomimetic asymmetric reduction of benzoxazinones and quinoxalinones using ureas as transfer catalysts.
Topics: Benzoxazines; Biomimetic Materials; Catalysis; Cell Cycle Proteins; Coordination Complexes; Hydrogen Bonding; Models, Chemical; Molecular Conformation; NAD; Niacinamide; Oxidation-Reduction; Quinoxalines; Ruthenium; Substrate Specificity; Transcription Factors; Urea | 2020 |
Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; I-kappa B Kinase; Mice; Molecular Structure; Pancreatic Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Quinoxalines; Structure-Activity Relationship; Urea | 2021 |